BSA
ACL

Braun Stacey Associates’s Alcon CHF 0.20 PAR VALUE ACL Stock Holding History

Braun Stacey Associates’s Portfolio ACL Stock Details ACL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-15,050
Closed – – 314
2015
Q2 		$0 Buy
+15,050
New – ﹤0.01% 318

Braun Stacey Associates's ACL Position: Q3 2015 in Review

Braun Stacey Associates sold out of Alcon CHF 0.20 PAR VALUE (ACL) in Q3 2015, closing a stake of 15,050 shares.

Braun Stacey Associates first reported a position in ACL in Q2 2015 and held it in 1 quarter. The position peaked at $0 in Q2 2015. 0 funds tracked by Wall St. Rank hold ACL as of Q3 2015.

  • Braun Stacey Associates reported no remaining Alcon CHF 0.20 PAR VALUE position as of Q3 2015 after selling out during the quarter.
  • Braun Stacey Associates sold 15,050 Alcon CHF 0.20 PAR VALUE shares in Q3 2015.
  • Braun Stacey Associates first reported a position in Alcon CHF 0.20 PAR VALUE in Q2 2015 and held it in 1 quarter.
  • Braun Stacey Associates's Alcon CHF 0.20 PAR VALUE position peaked at $0 in Q2 2015.
  • 0 funds tracked by Wall St. Rank held Alcon CHF 0.20 PAR VALUE as of Q3 2015.

Based on Braun Stacey Associates's 13F filing for Q3 2015, filed 1 Dec 2015.